(difelikefalin)
A range of helpful downloadable resources and information on
Ferinject® (ferric carboxymaltose) and iron deficiency to support
your treatment goals for patients with heart failure (HF) and CKD
Heart failure pocket guide
Understand the potential consequences of iron deficiency and how to diagnose and treat patients with HF
AFFIRM-AHF STUDY SUMMARY
Explore the results of AFFIRM-AHF, a clinical trial that evaluated the effects of treatment of iron deficiency with Ferinject vs placebo in patients with HF
5 REASONS TO CONSIDER FERINJECT LEAFLET
Find out how Ferinject may benefit ND-CKD patients with iron deficient anaemia, including its efficacy, safety profile and convenient administration
FERINJECT CHECKLIST
Use this checklist to document details of patients who are prescribed Ferinject for iron deficiency and aid with its correct administration
FERINJECT PATIENT LEAFLET
A leaflet to be given to patients who have been prescribed Ferinject to help understand what it is and what they can expect from their treatment
CKD, chronic kidney disease; HF, heart failure; ND-CKD, non-dialysis chronic kidney disease.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Pharma UK Ltd. (Tel 01276 853633). Email: medicalinfo_UK@viforpharma.com
Welcome to
Help us guide you to the right place:
I am a UK healthcare
professional or UK healthcare
decision maker
This is me, continue 
I am not a UK healthcare
professional or UK healthcare
decision maker
This is me, continue